Michael Rhodes has left Life Technologies to join NanoString Technologies. At NanoString, Rhodes will be the director of collaboration and applications development and focus on digital gene expression technologies.
Rhodes held various positions at Life Tech, including most recently senior manager of the sequencing portfolio. He joined Applied Biosystems in 1999 in the genetic analysis division before the company merged with Invitrogen and became Life Tech.
In his new position, Rhodes will report to Joe Beechem, who also recently came to NanoString from Life Tech, where he was most recently vice president, head of advanced sequencing and head of global sequencing chemistry, biochemistry, and biophysics.